Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
Lasica, Masa, Anderson, Mary A., Boussioutas, Alex, Gregory, Gareth P., Hamad, Nada, Manos, Kate, McKelvie, Penny, Ng, Michael, Campbell, Belinda, Palfreyman, Emma, Salvaris, Ross, Weinkove, Robert, Wight, Joel, Opat, Stephen, and Tam, Constantine (2024) Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal, 54 (6). pp. 1017-1030.
![]() |
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
Marginal zone lymphomas (MZLs) are a rare, indolent group of non-Hodgkin lymphomas with different diagnostic, genetic and clinical features and therapeutic implications. The most common is extranodal MZL of mucosa-associated lymphoid tissue, followed by splenic MZL and nodal MZL. Patients with MZL generally have good outcomes with long survival rates but frequently have a relapsing/remitting course requiring several lines of therapy. The heterogeneous presentation and relapsing course present the clinician with several diagnostic and therapeutic challenges. This position statement presents evidence-based recommendations in the setting of Australia and New Zealand.
Item ID: | 85790 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1445-5994 |
Copyright Information: | © 2024 Royal Australasian College of Physicians. |
Date Deposited: | 11 Jun 2025 01:07 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321102 Cancer diagnosis @ 100% |
SEO Codes: | 28 EXPANDING KNOWLEDGE > 2801 Expanding knowledge > 280103 Expanding knowledge in the biomedical and clinical sciences @ 100% |
Downloads: |
Total: 1 Last 12 Months: 1 |
More Statistics |